S. De Leo, S.Y. Lee, L.E. Braverman, Hyperthyroidism. Lancet Lond. Engl. 388(10047), 906–918 (2016). https://doi.org/10.1016/S0140-6736(16)00278-6
P. N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J. H. Lazarus, C. M. Dayan, O. E. Okosieme, Global epidemiology of hyperthyroidism and hypothyroidism. Nature reviews. Endocrinology 14(5), 301–316 (2018). https://doi.org/10.1038/nrendo.2018.18
K. Poppe, P. Bisschop, L. Fugazzola, G. Minziori, D. Unuane, A. Weghofer, 2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction. Eur. Thyroid J. 9(6), 281–295 (2021). https://doi.org/10.1159/000512790
J.G. Hollowell, N.W. Staehling, W.D. Flanders et al. Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87(2), 489–499 (2002). https://doi.org/10.1210/jcem.87.2.8182
C. Dosiou, Thyroid and Fertility: Recent Advances. Thyroid J. Am. Thyroid Assoc. 30(4), 479–486 (2020). https://doi.org/10.1089/thy.2019.0382
K. Poppe, Management of Endocrine Disease: Thyroid and female infertility: more questions than answers?! Eur. J. Endocrinol. 184(4), R123–R135 (2021). https://doi.org/10.1530/EJE-20-1284
M.A. Bedaiwy, M.Y. Abdel-Rahman, J. Tan et al. Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study. J. Womens Health 27(5), 659–664 (2018). https://doi.org/10.1089/jwh.2017.6584
T.I.M. Korevaar, L. Mínguez-Alarcón, C. Messerlian et al. Association of Thyroid Function and Autoimmunity with Ovarian Reserve in Women Seeking Infertility Care. Thyroid J. Am. Thyroid Assoc. 28(10), 1349–1358 (2018). https://doi.org/10.1089/thy.2017.0582
H.M. Sadeghi, I. Adeli, D. Calina et al. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J. Mol. Sci. 23(2), 583 (2022). https://doi.org/10.3390/ijms23020583
A.H. Balen, G.S. Conway, G. Kaltsas et al. Andrology: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum. Reprod. 10(8), 2107–2111 (1995). https://doi.org/10.1093/oxfordjournals.humrep.a136243
S. Parveen, S. Das, Homeopathic Treatment in Patients with Polycystic Ovarian Syndrome: A Case Series. Homeopath. J. Fac. Homeopath. 110(3), 186–193 (2021). https://doi.org/10.1055/s-0041-1725039
J. Puurunen, T. Piltonen, L. Morin-Papunen, A. Perheentupa, I. Järvelä, A. Ruokonen, J. S. Tapanainen, Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J. Clin. Endocrinol. Metab. 96(6), 1827–1834 (2011). https://doi.org/10.1210/jc.2011-0039
J. Collée, M. Mawet, L. Tebache, M. Nisolle, G. Brichant, Polycystic ovarian syndrome and infertility: overview and insights of the putative treatmentsGynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology, 37(10), 869–874 (2021). https://doi.org/10.1080/09513590.2021.1958310
H. Teede, A. Deeks, L. Moran, Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC medicine, 8, 41 (2010). https://doi.org/10.1186/1741-7015-8-41
I.M. Gawron, R. Baran, K. Derbisz, R. Jach, Association of Subclinical Hypothyroidism with Present and Absent Anti-Thyroid Antibodies with PCOS Phenotypes and Metabolic Profile. J. Clin. Med. 11(6), 1547 (2022). https://doi.org/10.3390/jcm11061547
A. Arduc, B. Aycicek Dogan, S. Bilmez et al. High prevalence of Hashimoto’s thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role? Endocr. Res. 40(4), 204–210 (2015). https://doi.org/10.3109/07435800.2015.1015730
C.W. Ho, H.H. Chen, M.C. Hsieh et al. Increased Risk of Polycystic Ovary Syndrome and It’s Comorbidities in Women with Autoimmune Thyroid Disease. Int J. Environ. Res. Public Health 17(7), 2422 (2020). https://doi.org/10.3390/ijerph17072422
M. Sharma, A. Modi, M. Goyal, P. Sharma, P. Purohit, Anti-thyroid antibodies and the gonadotrophins profile (LH/FSH) in euthyroid polycystic ovarian syndrome women. Acta Endocrinol. Buchar. Rom. 18(1), 79–85 (2022). https://doi.org/10.4183/aeb.2022.79
C. De Geyter, L. Matt, I. De Geyter, R. Moffat, C. Meier, In infertile women with subclinical hypothyroidism, with or without thyroid peroxidase antibodies, serum TSH during pregnancy follows preconception values and thyroid hormones remain stable. Hum. Reprod. Open 2023(4), hoad038 (2023). https://doi.org/10.1093/hropen/hoad038
C.A. Emdin, A.V. Khera, S. Kathiresan, Mendelian Randomization. JAMA 318(19), 1925–1926 (2017). https://doi.org/10.1001/jama.2017.17219
A. Teumer, L. Chaker, S. Groeneweg et al. Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation. Nat. Commun. 9(1), 4455 (2018). https://doi.org/10.1038/s41467-018-06356-1
Article ADS CAS Google Scholar
F. Day, T. Karaderi, M.R. Jones et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 14(12), e1007813 (2018). https://doi.org/10.1371/journal.pgen.1007813
M. I. Kurki, J. Karjalainen, P. Palta, T. P. Sipilä, K. Kristiansson, K. M. Donner, M. P. Reeve, H. Laivuori, M. Aavikko, M. A. Kaunisto, A. Loukola, E. Lahtela, H. Mattsson, P. Laiho, P. Della Briotta Parolo, A. A. Lehisto, M. Kanai, N. Mars, J. Rämö, T. Kiiskinen, … A. Palotie, FinnGen provides genetic insights from a well-phenotyped isolated population. Nature, 613(7944), 508–518 (2023). https://doi.org/10.1038/s41586-022-05473-8
J.S. Tyrmi, R.K. Arffman, N. Pujol-Gualdo et al. Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome. Hum. Reprod. Oxf. Engl. 37(2), 352–365 (2022). https://doi.org/10.1093/humrep/deab250
J. M. Fussey, R. N. Beaumont, A. R. Wood, B. Vaidya, J. Smith, J. Tyrrell, Does Obesity Cause Thyroid Cancer? A Mendelian Randomization Study. J. Clin. Endocrinol. Metab. 105(7), e2398–e2407 (2020). https://doi.org/10.1210/clinem/dgaa250
GIANT Consortium, P. Wojciechowski, A. Lipowska et al. Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia 55(10), 2636–2645 (2012). https://doi.org/10.1007/s00125-012-2638-6
C. J. Glueck, N. Goldenberg, Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism: clinical and experimental, 92, 108–120 (2019). https://doi.org/10.1016/j.metabol.2018.11.002
Q. Liu, Z. Zhu, P. Kraft, Q. Deng, E. Stener-Victorin, X. Jiang, Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis. BMC medicine, 20(1), 66 (2022). https://doi.org/10.1186/s12916-022-02238-y
C. Yao, Y. Zhang, P. Lu et al. Exploring the bidirectional relationship between pain and mental disorders: a comprehensive Mendelian randomization study. J. Headache Pain. 24(1), 82 (2023). https://doi.org/10.1186/s10194-023-01612-2
L. Chen, H. Yang, H. Li, C. He, L. Yang, G. Lv, Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study. Hepatology (Baltimore, Md.) 75(4), 785–796. (2022). https://doi.org/10.1002/hep.32183
Y. Guo, Y. Dai, H. Yu, S. Zhao, D.C. Samuels, Y. Shyr, Improvements and impacts of GRCh38 human reference on high throughput sequencing data analysis. Genomics 109(2), 83–90 (2017). https://doi.org/10.1016/j.ygeno.2017.01.005
S. Burgess, A. Butterworth, S.G. Thompson, Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 37(7), 658–665 (2013). https://doi.org/10.1002/gepi.21758
J. Bowden, M. F. Del Greco, C. Minelli, G. Davey Smith, N. A. Sheehan, J. R. Thompson, Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int. J. Epidemiol. 45(6), 1961–1974 (2016). https://doi.org/10.1093/ije/dyw220
J. Bowden, G. Davey Smith, S. Burgess, Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J. Epidemiol. 44(2), 512–525 (2015). https://doi.org/10.1093/ije/dyv080
L. Xiao, S. Liu, Y. Wu et al. The interactions between host genome and gut microbiome increase the risk of psychiatric disorders: Mendelian randomization and biological annotation. Brain Behav. Immun. 113, 389–400 (2023). https://doi.org/10.1016/j.bbi.2023.08.003
D.A. Lawlor, L. Benfield, J. Logue et al. Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study. BMJ 341, c6224 (2010). https://doi.org/10.1136/bmj.c6224
F.P. Hartwig, N.M. Davies, G. Hemani, G. Davey Smith, Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J. Epidemiol. 45(6), 1717–1726 (2016). https://doi.org/10.1093/ije/dyx028
M. Verbanck, C.Y. Chen, B. Neale, R. Do, Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet 50(5), 693–698 (2018). https://doi.org/10.1038/s41588-018-0099-7
S. Burgess, G. Davey Smith, N.M. Davies et al. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res 4, 186 (2019). https://doi.org/10.12688/wellcomeopenres.15555.2
S. Burgess, G. Davey Smith, N.M. Davies et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 4, 186 (2023). https://doi.org/10.12688/wellcomeopenres.15555.3
留言 (0)